Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study Article

Subramanian, Sundaram, Prasanna, Rammohan, Biswas, Ghanashyam et al. (2020). Nanosomal Docetaxel Lipid Suspension-Based Chemotherapy in Breast Cancer: Results from a Multicenter Retrospective Study . BREAST CANCER-TARGETS AND THERAPY, 12 77-85. 10.2147/BCTT.S236108

Open Access International Collaboration

cited authors

  • Subramanian, Sundaram; Prasanna, Rammohan; Biswas, Ghanashyam; Das Majumdar, Saroj Kumar; Joshi, Nisarg; Bunger, Deepak; Khan, Mujtaba A; Ahmad, Imran

sustainable development goals

authors

publication date

  • January 1, 2020

published in

keywords

  • ADJUVANT DOCETAXEL
  • CARBOPLATIN
  • CYCLOPHOSPHAMIDE
  • DOCEAQUALIP
  • DoceAqualip
  • EFFICACY
  • FORMULATION
  • HYPERSENSITIVITY REACTIONS
  • Life Sciences & Biomedicine
  • NDLS
  • NEOADJUVANT DOCETAXEL
  • Oncology
  • Science & Technology
  • TRASTUZUMAB
  • TRIAL
  • breast cancer
  • nanosomal docetaxel lipid suspension

Digital Object Identifier (DOI)

publisher

  • DOVE MEDICAL PRESS LTD

start page

  • 77

end page

  • 85

volume

  • 12